Keywords
xavotir buzilishi
benzodiazepinlar
diazepam
alprazolam
How to Cite
Abstract
Anksiolitiklar — xavotir, ichki bezovtalik, zo‘riqish, qo‘rquv va psixoemotsional taranglikni kamaytirish uchun qo‘llaniladigan psixotrop dori vositalari guruhidir. Ular generalizatsiyalangan xavotir buzilishi, panik buzilish, ijtimoiy fobiya, uyqusizlik, vegetativ qo‘zg‘alish, mushak tarangligi, alkogol abstinensiyasi, premedikatsiya va ayrim nevrotik holatlarda qo‘llaniladi. Jahon sog‘liqni saqlash tashkiloti ma’lumotlariga ko‘ra, 2021-yilda dunyoda 359 million kishi xavotir buzilishlari bilan yashagan, bu esa global aholining taxminan 4,4 foizini tashkil etadi. Shu sababli xavotir buzilishlarini erta aniqlash va ratsional davolash zamonaviy tibbiyotda muhim ahamiyatga ega.
References
1. World Health Organization. Anxiety disorders. 2025.
2. Bounds C.G., et al. Benzodiazepines. StatPearls, NCBI Bookshelf. 2024.
3. Kang M., et al. Benzodiazepine Toxicity. StatPearls, NCBI Bookshelf. 2023.
4. Edwards Z., et al. GABA Receptor Positive Allosteric Modulators. StatPearls, NCBI Bookshelf. 2024.
5. Garakani A., et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry. 2020.
6. Melaragno A.J. Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance. Focus. 2021.
7. Strawn J.R., et al. Pharmacotherapy for Generalized Anxiety Disorder in Adults and Pediatric Patients. Expert Opinion on Pharmacotherapy. 2018.
8. Cardoner N., et al. Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? Systematic review and meta-analysis. 2025.
9. National Institute of Mental Health. Anxiety Disorders.
10. Bie F., et al. Rising global burden of anxiety disorders among adolescents and young adults. 2024.
